Dolby Laboratories (DLB) EBITDA Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Relx |
81.40 Bn |
81.16 Bn |
- |
- |
| 2 |
Rentokil Initial |
79.56 Bn |
78.10 Bn |
- |
- |
| 3 |
Cintas |
69.26 Bn |
69.08 Bn |
1.45 Bn |
-15.00 |
| 4 |
Copart |
33.09 Bn |
28.01 Bn |
971.24 Mn |
-198.00 |
| 5 |
UL Solutions |
20.56 Bn |
20.32 Bn |
381.00 Mn |
274.00 |
| 6 |
Global Payments |
19.88 Bn |
14.69 Bn |
1.70 Bn |
-2,096.00 |
| 7 |
Rb Global |
19.08 Bn |
18.89 Bn |
869.50 Mn |
-185.00 |
| 8 |
Aramark |
13.57 Bn |
13.16 Bn |
426.35 Mn |
41.00 |
| 9 |
Amentum Holdings |
5.65 Bn |
5.74 Bn |
345.00 Mn |
119.00 |
| 10 |
Dolby Laboratories |
5.15 Bn |
4.56 Bn |
350.90 Mn |
-61.00 |
| Date | Value |
| Mar 27, 2026 |
-61.00 |
| Dec 26, 2025 |
-445.00 |
| Sep 26, 2025 |
-554.00 |
| Jun 27, 2025 |
236.00 |
| Mar 28, 2025 |
-73.00 |
| Dec 27, 2024 |
139.00 |
| Sep 27, 2024 |
1,641.00 |
| Jun 28, 2024 |
740.00 |
| Mar 29, 2024 |
84.00 |
| Dec 29, 2023 |
-711.00 |
| Sep 29, 2023 |
-1,095.00 |
| Jun 30, 2023 |
-1,039.00 |
| Mar 31, 2023 |
1,609.00 |
| Dec 30, 2022 |
233.00 |
| Sep 30, 2022 |
-442.00 |
| Jul 1, 2022 |
-382.00 |
| Apr 1, 2022 |
-1,307.00 |
| Dec 31, 2021 |
-1,650.00 |
| Sep 24, 2021 |
307.00 |
| Jun 25, 2021 |
573.00 |
| Mar 26, 2021 |
-408.00 |
| Dec 25, 2020 |
2,561.00 |
| Sep 25, 2020 |
-605.00 |
| Jun 26, 2020 |
249.00 |
| Mar 27, 2020 |
-32.00 |
| Dec 27, 2019 |
-606.00 |
| Sep 27, 2019 |
1,192.00 |
| Jun 28, 2019 |
1,488.00 |
| Mar 29, 2019 |
220.00 |
| Dec 28, 2018 |
-866.00 |
| Sep 28, 2018 |
-8,660.00 |
| Jun 29, 2018 |
-3,493.00 |
| Mar 30, 2018 |
-120,200.00 |
| Dec 29, 2017 |
-20,282.00 |
| Sep 29, 2017 |
-56,576.00 |
| Jun 30, 2017 |
-36,204.00 |
| Mar 31, 2017 |
-43,597.00 |
| Dec 30, 2016 |
-56,950.00 |
| Sep 30, 2016 |
64,206.00 |
| Jul 1, 2016 |
19,452.00 |